Shelter Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 to consider, approve and take on record the Audited Financial Results for the half year ended and year ended on March 31, 2024 as per Regulation 33 of the SEBI (LODR) Regulation, 2015.
The above information is a part of company’s filings submitted to BSE.